Abveris on-demand webinar 09/02/2021

100 Anti-Idiotype Antibody Discovery Projects: A Retrospective

Speakers

Ryan Kelly, Director of Business Development of Abveris

Topics of Discussion:
● Lessons learned from 100 anti-ID projects: key challenges and considerations
● The advantages of Abveris anti-idiotype discovery workflows (single B cell and optimized hybridoma) as compared to other discovery methods
● The advantages of incorporating genetically modified hyperimmune mouse models (DiversimAb™) into in vivo antibody discovery workflows (affinity, epitopic coverage, function) 
● Case studies highlighting rapid antibody discovery against therapeutics antibodies and cell-based products